Adjuvant Durvalumab in Completely Resected Early-Stage Non–Small Cell Lung Cancer

Adjuvant durvalumab following complete resection was not associated with improvement in DFS compared with placebo in <i>EGFR</i>-/<i>ALK</i>- NSCLC, regardless of PD-L1 status.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2026-01-13
DOI
https://doi.org/10.1200/jco-25-01828
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adjuvant Durvalumab in Completely Resected Early-Stage Non–Small Cell Lung Cancer

M. Stockler, A. Catino, M. Okada, C. Audigier-Valette et al.
Journal of Clinical Oncology
Lung Cancer Diagnosis and Treatment
article

Adjuvant Durvalumab in Completely Resected Early-Stage Non–Small Cell Lung Cancer

M. Stockler, A. Catino, M. Okada, C. Audigier-Valette, Gail Darling, K. Nakagawa, A. Dingemans, Tetsuya Mitsudomi, Franck Morin, G A Goss, Christopher James O'Callaghan, Manuel Dmine, Ernest Nadal, Keyue Ding, Rafal Dziadziuszko, Shunichi Sugawara, Renaud Whittom, Virginie Westeel, Bartomeu Massutí, Penelope A. Bradbury, Laurent Greillier, Anne-Claire Toffart, Olivier Molinier, Nobuyuki Yamamoto, Yi-Long Wu, Jin Hyoung Kang
article en

Abstract

Adjuvant durvalumab following complete resection was not associated with improvement in DFS compared with placebo in <i>EGFR</i>-/<i>ALK</i>- NSCLC, regardless of PD-L1 status.

Journal of Clinical OncologyVol. 44(7)
Hiroshima University (JP), Centre National de la Recherche Scientifique (FR), The University of Sydney (AU), Dalhousie University (CA), Inserm (FR), University of Toronto (CA), Wakayama Medical University (JP), Queen's University (CA), Aix-Marseille Université (FR), Centre Hospitalier Universitaire de Grenoble (FR), Ottawa Hospital (CA), Bellvitge University Hospital (ES), Princess Margaret Cancer Centre (CA), St Vincent's Hospital Melbourne (AU), Centre Hospitalier Universitaire de Besançon (FR), Kindai University Hospital (JP), Intergroupe Francophone de Cancérologie Thoracique (FR), Centre Hospitalier du Mans (FR), Hospital Universitario Fundación Jiménez Díaz (ES), Istituto Tumori Bari (IT), Nisshin Scientia (Japan) (JP), Hospital General Universitario de Alicante Doctor Balmis (ES), Hôpital d'Instruction des Armées Sainte-Anne (FR), Hôpital du Sacré-Cœur de Montréal (CA), Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT), Guangdong Academy of Medical Sciences (CN), Erasmus MC Cancer Institute (NL), Centre Hospitalier Intercommunal Toulon-La Seyne-sur-Mer (FR), St. Paul's Hospital (KR), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Guangdong Provincial People's Hospital (CN), The Catholic University of Korea Seoul St. Mary's Hospital (KR), National Health and Medical Research Council (AU), Southern Medical University (CN), Universidad Autónoma de Madrid (ES), Gdańsk Medical University (PL), Université Grenoble Alpes (FR), Kindai University (JP)
Good health and well-being
Openalex Percentile: Top 89%
Lung Cancer Diagnosis and Treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.